Daiichi Sankyo: Neoplasm Metastasis trials

The registry lists 11 Neoplasm Metastasis studies with Daiichi Sankyo as lead sponsor. 3 are open to participants now and 4 have results posted.

Phase 1 6Phase 2 2Phase 3 2Phase 4 1No phase 1(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• First-in-Human Trial of DS1025a in Participants With Advanced Solid TumorsRecruitingNCT07681882Phase 1
• A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s)RecruitingNCT06174987Phase 3
• First-in-Human Study of DS-3939a in Participants With Advanced Solid TumorsRecruitingNCT05875168Phase 1/2
• Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]CompletedNCT03734029Phase 3Results posted
• Study of DS-8201a for Participants With Advanced Solid Malignant TumorsCompletedNCT03383692Phase 1Results posted
• A Study of DS-8201a in Metastatic Breast Cancer Previously Treated With Trastuzumab Emtansine (T-DM1)TerminatedNCT03248492Phase 2Results posted
• Treatment Response of Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia (IDA) Secondary to Inflammatory Bowel Disease (IBD) or Gastric BypassCompletedNCT02086968Phase 4Results posted
• Study on Prevalence and Impact of Brain Metastases on Survival in Lung Cancer by Line of TreatmentCompletedNCT06557967
• A Study of DS-9606a in Patients With Advanced Solid TumorsTerminatedNCT05394675Phase 1
• A Study Evaluating DS-1055a in Participants With Relapsed or Refractory Locally Advanced or Metastatic Solid TumorsActive, not recruitingNCT04419532Phase 1
• U3-1402 in Metastatic or Unresectable Non-Small Cell Lung CancerActive, not recruitingNCT03260491Phase 1